TrialStem cells translational medicine2026
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Yi-Chun Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.